[Form 4] Teladoc Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Teladoc Health, Inc. reported that Carlos Nueno, its President, International, exercised restricted stock units and sold shares primarily to cover taxes. On June 1, 2026, he converted a total of 13,272 restricted stock units into the same number of Teladoc common shares at a conversion price of $0.00 per share, with the units converting on a one-for-one basis into common stock.

On June 2, 2026, Nueno sold 6,196 shares of common stock at an average price of $7.627 per share. A footnote explains these shares were sold to cover the tax withholding obligation related to the vesting of his restricted stock unit awards, indicating a tax-driven disposition rather than a discretionary open-market sale. After these transactions, he directly held 57,671 shares of Teladoc common stock and 13,670 restricted stock units.

The filing also notes earlier equity grants, including 54,675 restricted stock units granted on March 19, 2024 and 104,602 restricted stock units granted on March 1, 2025, both subject to multi-year vesting schedules. These awards illustrate that a significant portion of Nueno’s compensation remains tied to Teladoc’s future share performance through ongoing RSU vesting.

Insights

Equity compensation specialist

Routine RSU vesting with tax-driven share sale, limited signaling value.

Carlos Nueno converted 13,272 restricted stock units into Teladoc common shares and then sold 6,196 shares at $7.627 on June 2, 2026. Footnotes state the sale was to satisfy tax withholding from RSU vesting, a common, mechanistic step in equity compensation.

Because the disposition is tax-driven rather than a discretionary portfolio decision, its informational value about Nueno’s view on Teladoc Health, Inc. is limited. He still holds 57,671 common shares and 13,670 RSUs, plus sizeable unvested awards from grants on March 19, 2024 and March 1, 2025, keeping his incentives aligned with long-term share performance.

Insider Trade Summary

Net Seller: 6,196 shares ($47,257)

Net Sell 5 txns

Insider Nueno Carlos

Role President, International

Sold 6,196 shs ($47K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,196	$7.627	$47K
Exercise	Restricted Stock Units	4,556	$0.00	--
Exercise	Restricted Stock Units	8,716	$0.00	--
Exercise	Common Stock	4,556	$0.00	--
Exercise	Common Stock	8,716	$0.00	--

Holdings After Transaction: Common Stock — 57,671 shares (Direct, null); Restricted Stock Units — 13,670 shares (Direct, null)

Footnotes (1)

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Key Figures

Shares sold: 6,196 shares Sale price: $7.627 per share RSUs converted: 13,272 units +4 more

7 metrics

Shares sold 6,196 shares Common stock sold at $7.627 on June 2, 2026

Sale price $7.627 per share Average price for 6,196 Teladoc shares sold

RSUs converted 13,272 units Restricted stock units converted to common on June 1, 2026

Common shares held 57,671 shares Direct Teladoc common stock holdings after transactions

RSUs outstanding 13,670 units Restricted stock units remaining after exercises

2024 RSU grant 54,675 units Grant on March 19, 2024 with multi-year vesting

2025 RSU grant 104,602 units Grant on March 1, 2025 with vesting starting March 1, 2026

Key Terms

Restricted stock units, open-market sale, tax withholding obligation, vesting, +1 more

5 terms

Restricted stock units financial

"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

open-market sale financial

"transaction_action": "open-market sale", "transaction_code_description": "Sale in open market or private transaction""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax withholding obligation financial

"Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards."

vesting financial

"vests one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

one-for-one basis financial

"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nueno Carlos

(Last) (First) (Middle)

C/O TELADOC HEALTH, INC.,

155 E 44TH ST, SUITE 1700

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, International

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		M		4,556	A	(1)	55,151	D
Common Stock	06/01/2026		M		8,716	A	(1)	63,867	D
Common Stock	06/02/2026		S		6,196(2)	D	$7.627	57,671	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/01/2026		M			4,556	(3)	(3)	Common Stock	4,556	$0	13,670	D
Restricted Stock Units	(1)	06/01/2026		M			8,716	(4)	(4)	Common Stock	8,716	$0	61,019	D

Explanation of Responses:

1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

2. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

3. On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.

4. On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Remarks:

	/s/ Adam C. Vandervoort, Attorney-in-Fact	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)